Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGIR | P43119 | 9/20 | 0.71 |
| ▸ | PTGER2 | P43116 | 6/20 | 0.71 |
| ▸ | TSHR | P16473 | 3/20 | 0.71 |
| ▸ | PTGER4 | P35408 | 3/20 | 0.71 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.71 |
| ▸ | HPGD | P15428 | 2/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.71 |
| ▸ | RARB | P10826 | 1/20 | 0.71 |
| ▸ | RARG | P13631 | 1/20 | 0.71 |
| ▸ | DRD1 | P21728 | 1/20 | 0.71 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.71 |
| ▸ | PGR | P06401 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11792290 | 1.00 | PTGIR (0.71) | PTGIRPTGER2TSHRPTGER4ABCC4 | |
| SCHEMBL11866030 | 1.00 | PTGIR (0.71) | PTGIRPTGER2TSHRPTGER4ABCC4 | |
| SCHEMBL9487052 | 1.00 | PTGIR (0.71) | PTGIRPTGER2TSHRPTGER4ABCC4 | |
| SCHEMBL11866009 | 1.00 | PTGIR (0.71) | PTGIRPTGER2TSHRPTGER4ABCC4 | |
| SCHEMBL11866020 | 1.00 | PTGIR (0.71) | PTGIRPTGER2TSHRPTGER4ABCC4 | |
| SCHEMBL23352661 | 1.00 | PTGIR (0.71) | PTGIRPTGER2TSHRPTGER4ABCC4 | |
| SCHEMBL7744904 | 1.00 | PTGIR (0.71) | PTGIRPTGER2TSHRPTGER4ABCC4 | |
| SCHEMBL23352592 | 1.00 | PTGIR (0.71) | PTGIRPTGER2TSHRPTGER4ABCC4 | |
| SCHEMBL7744902 | 1.00 | PTGIR (0.71) | PTGIRPTGER2TSHRPTGER4ABCC4 | |
| SCHEMBL11812297 | 1.00 | PTGIR (0.71) | PTGIRPTGER2TSHRPTGER4ABCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116508787-B | Urtica thunbergii leaf extract and preparation method and application thereof | 贵州农业职业学院 | 2025-02-18 | — | — | CN | claimed |
| EP-4413988-A1 | KERATIN POWDER FOR TOPICAL APPLICATION AND USE OF THE COLLOIDAL SOLUTION AND KERATIN POWDER | Rigi Therapeutics AG (CH) | 2024-08-14 | — | — | EP | claimed |
| EP-4659739-A9 | TOPICAL FORMULATION COMPRISING NON-COVALENT KERATIN-ACTIVE AGENT CONJUGATES FOR THERAPEUTIC USE | Rigi Therapeutics AG (CH) | 2026-04-29 | — | — | EP | disclosed |
| US-20250387332-A1 | LIPOSOMAL COMPOSITION CONTAINING MILD ACIDIC ACTIVE AGENT | TAIWAN LIPOSOME CO., LTD. (TW) | 2025-12-25 | — | — | US | disclosed |
| EP-4659739-A1 | TOPICAL FORMULATION COMPRISING NON-COVALENT KERATIN-ACTIVE AGENT CONJUGATES FOR THERAPEUTIC USE | Rigi Therapeutics AG (CH) | 2025-12-10 | — | — | EP | disclosed |
| EP-4659738-A1 | TOPICAL FORMULATION CONTAINING KERATIN PARTICLES FOR DERMATOLOGICAL USE | Rigi Therapeutics AG (CH) | 2025-12-10 | — | — | EP | disclosed |
| US-12419837-B2 | Liposomal composition containing mild acidic active agent | TAIWAN LIPOSOME CO., LTD. (TW) | 2025-09-23 | — | — | US | disclosed |
| EP-4552632-A1 | LIPOSOMAL COMPOSITION CONTAINING MILD ACIDIC ACTIVE AGENT | Taiwan Liposome Co., Ltd. (TW) | 2025-05-14 | — | — | EP | disclosed |
| CN-116508787-B | Urtica thunbergii leaf extract and preparation method and application thereof | 贵州农业职业学院 | 2025-02-18 | — | — | CN | disclosed |
| EP-3496704-B1 | LIPOSOMAL COMPOSITION CONTAINING MILD ACIDIC ACTIVE AGENT | TAIWAN LIPOSOME CO LTD (TW) | 2025-01-29 | — | — | EP | disclosed |
| US-20240382536-A1 | BACTERIA ENGINEERED TO TREAT A DISEASE OR DISORDER | SYNLOGIC, INC. | 2024-11-21 | — | — | US | disclosed |
| US-20230226122-A1 | MICROORGANISMS PROGRAMMED TO PRODUCE IMMUNE MODULATORS AND ANTI-CANCER THERAPEUTICS IN TUMOR CELLS | SYNLOGIC OPERATING COMPANY, INC. | 2023-07-20 | — | — | US | disclosed |
| CN-116457014-A | Mitochondrial biosynthesis and function enhancement by inhibition of prostaglandin degrading enzyme 15-PGDH | 莱兰斯坦福初级大学评议会 | 2023-07-18 | — | — | CN | disclosed |
| CN-116133683-A | Regeneration of aged tissues and organs by inhibition of the PGE2 degrading enzyme 15-PGDH | 莱兰斯坦福初级大学评议会 | 2023-05-16 | — | — | CN | disclosed |
| US-11471494-B2 | Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells | SYNLOGIC OPERATING COMPANY, INC. (US) | 2022-10-18 | — | — | US | disclosed |
| EP-4055007-A1 | PROSTAGLANDIN ANALOGS AND USES THEREOF | Lifex Biolabs, Inc. (US) | 2022-09-14 | — | — | EP | disclosed |
| WO-2022186170-A1 | COMPOSITION FOR PREVENTING OR TREATING CEREBROVASCULAR ACCIDENT | 公益財団法人東京都医学総合研究所 | 2022-09-09 | — | — | WO | disclosed |
| WO-2022073127-A1 | LIVE BIOTHERAPEUTICS SECRETING SYNTHETIC BACTERIOPHAGES IN THE TREATMENT OF CANCER | TATUM BIOSCIENCE INC. (CA) | 2022-04-14 | — | — | WO | disclosed |
| CN-114206337-A | Method for rejuvenating aged tissue by inhibiting 15-hydroxyprostaglandin dehydrogenase (15-PGDH) | 莱兰斯坦福初级大学评议会 | 2022-03-18 | — | — | CN | disclosed |
| US-20210139435-A1 | PROSTAGLANDIN ANALOGS AND USES THEREOF | Lifex Biolabs, Inc. | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250387332-A1 | LIPOSOMAL COMPOSITION CONTAINING MILD ACIDIC ACTIVE AGENT | LIPA, PTGER1, ALPG | PTGIR 188/4885PTGER2 8/4885TSHR 4541/4885 |
| US-20210139435-A1 | PROSTAGLANDIN ANALOGS AND USES THEREOF | PTGDR, NR3C1, PTGIR | PTGIR 3/4885PTGER2 18/4885TSHR 218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.